Athenex, Inc.

Home » Athenex, Inc.

Secondary

Athenex, Inc.

They are a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of cancer.

Symbol

ATNX

Last Closing Price
$15.47

Shares
4,300,000

Effective Date
January 25, 2018

Underwriters
Deutsche Bank, RBC Capital

To view the prospectus for Athenex, Inc., or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC 8601 N Scottsdale Rd, Suite 335, Scottsdale, AZ 85253